PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
- Conditions
- Castration-Resistant Prostate Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1199
- Registration Number
- NCT00974311
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Mayo Clinic Hospital, Phoenix, Arizona, United States
🇺🇸Premiere Oncology of Arizona, Scottsdale, Arizona, United States
A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients
- First Posted Date
- 2009-09-04
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00971893
A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers
- First Posted Date
- 2009-09-04
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT00971802
- Locations
- 🇺🇸
Pfizer Investigational Site, South Miami, Florida, United States
A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804
- First Posted Date
- 2009-09-03
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 22
- Registration Number
- NCT00971191
- Locations
- 🇺🇸
Pfizer Investigational Site, Los Angeles, California, United States
Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin
- First Posted Date
- 2009-09-02
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 92
- Registration Number
- NCT00970593
- Locations
- 🇺🇸
Profil Institute for Clincal Research, Chula Vista, California, United States
🇺🇸Cetero Research - Miami, Miami Gardens, Florida, United States
A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function
- First Posted Date
- 2009-09-01
- Last Posted Date
- 2010-02-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT00969813
- Locations
- 🇺🇸
Pfizer Investigational Site, South Miami, Florida, United States
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT00965731
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of California, Irvine Medical Center Pharmacy, Orange, California, United States
🇺🇸University of California, Irving - Medical Center, Orange, California, United States
Genotropin Study Assessing Use of Injection Pen
- Conditions
- Growth Hormone DeficiencyIdiopathic Short Stature
- Interventions
- Device: New Genotropin Pen
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2011-01-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 136
- Registration Number
- NCT00965484
- Locations
- 🇺🇸
Pfizer Investigational Site, Seattle, Washington, United States
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS
- Conditions
- HIV InfectionsPneumococcal Infections
- Interventions
- Biological: 13-valent pneumococcal conjugate vaccineProcedure: Blood draw
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2013-06-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 331
- Registration Number
- NCT00963235
- Locations
- 🇺🇸
Pfizer Investigational Site, Dallas, Texas, United States
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2014-06-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 127
- Registration Number
- NCT00962741
- Locations
- 🇪🇸
Pfizer Investigational Site, Valencia, Spain